PLAY PODCASTS
Contemporary Management of HIV: Evolving Issues in First-line  Combination Therapy
Episode 33

Contemporary Management of HIV: Evolving Issues in First-line Combination Therapy

Listen to expert insights from Joseph J. Eron, Jr., MD, and Daniel R. Kuritzkes, MD, on evolving considerations for first-line HIV therapy, including 2-drug regimens, weight gain, and pregnancy safety.

Decera Clinical Education Infectious Disease Podcast · Daniel R. Kuritzkes MD, Joseph J. Eron Jr. MD

December 29, 202031m 23s

Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In this episode, Joseph J. Eron, Jr., MD; and Daniel R. Kuritzkes, MD; discuss evolving issues in first-line antiretroviral therapy, including 2-drug therapy, weight gain, and safety during conception and pregnancy.

Presenters:

Joseph J. Eron, Jr., MD
Professor of Medicine and Epidemiology
University of North Carolina 
School of Medicine
Director, AIDS Clinical Trials Unit
University of North Carolina
Chapel Hill, North Carolina

Daniel R. Kuritzkes, MD
Chief, Division of Infectious Diseases
Brigham and Women’s Hospital
Harriet Ryan Albee Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Content based on an online CME program supported by an independent educational grant from ViiV Healthcare.

Link to full program:
http://bit.ly/34fVILZ


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Topics

dolutegravirbictaf pregnancyimpaact 2010 hivefavirenz pregnancydtgart weight gain2-drug artinitial arthiv treatment-naivedhhs guidelinesbic/ftc/taftenofovir alafenamide pregnancydual therapy artantiretroviral therapyhiv weight gaininstistsepamohiv geminiraldtg ntdsdolutegravir neural tube defectsftc/tdfftc/tafdtg/3tcfirst-line artartdolutegravir pregnancyhiv